Phase
Condition
Muscular Dystrophy
Treatment
VX-670
Placebo
Clinical Study ID
Ages 18-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
- Documented clinical diagnosis of DM1 with age of onset greater than (>) 1 year ofage and documented positive genetic test for DM1 in the subject with cytosinethymine guanine (CTG) repeat of at least 100
Exclusion
Key Exclusion Criteria:
- History of any illness or any clinical condition as pre-specified in the protocol
Other protocol defined Inclusion/Exclusion criteria may apply.
Study Design
Connect with a study center
Wesley Research Institute
Auchenflower,
AustraliaActive - Recruiting
Neuroscience Clinical Trials Unit, Alfred Brain
Melbourne,
AustraliaActive - Recruiting
Hopital de Chicoutimi
Chicoutimi,
CanadaActive - Recruiting
Altasciences Montreal
Mont-Royal,
CanadaActive - Recruiting
McGill University
Montreal,
CanadaActive - Recruiting
University of Ottawa
Ottawa,
CanadaActive - Recruiting
CHU Research Centre of Quebec
Quebec,
CanadaActive - Recruiting
Clinical Research Facility, Queen Elizabeth University Hospital
Glasgow,
United KingdomActive - Recruiting
St. George's University Hospital
London,
United KingdomActive - Recruiting
University College London
London,
United KingdomActive - Recruiting
Salford Royal Hospital
Salford,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.